What are the causes of metrorrhagia (irregular uterine bleeding)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Metrorrhagia

Primary Classification Framework

Metrorrhagia (irregular uterine bleeding) should be systematically evaluated using the PALM-COEIN classification system, which divides causes into structural (PALM) and non-structural (COEIN) etiologies. 1, 2, 3

Structural Causes (PALM)

The structural causes represent discrete anatomic abnormalities that can be visualized on imaging or hysteroscopy:

  • Polyps: Endometrial polyps are benign growths that protrude into the uterine cavity and cause irregular bleeding 2, 4, 5

  • Adenomyosis: Endometrial tissue within the myometrium, frequently coexisting with fibroids, presenting with heavy menstrual bleeding, dysmenorrhea, and dyspareunia, particularly common in women in their 40s 2, 3

  • Leiomyoma (Fibroids): Benign smooth muscle tumors, especially submucosal fibroids that distort the endometrial cavity 2, 4, 6

  • Malignancy and Hyperplasia: Endometrial hyperplasia (with or without atypia), endometrial cancer, cervical cancer, vaginal cancer, vulvar cancer, oviduct malignancies, and granulosa theca cell ovarian tumors 2, 4, 6

Non-Structural Causes (COEIN)

These causes do not involve discrete anatomic lesions:

  • Coagulopathy: Bleeding disorders, most commonly von Willebrand disease, which should be suspected in all adolescents with menorrhagia and women with high-risk factors 7, 5, 6

  • Ovulatory Dysfunction: Chronic anovulation from polycystic ovary syndrome, uncontrolled diabetes mellitus, thyroid dysfunction (hypothyroidism), hyperprolactinemia, and use of antipsychotics or antiepileptics 1, 7, 6

  • Endometrial: Primary endometrial disorders not related to structural pathology 2, 3

  • Iatrogenic: Sex steroids, hypothalamic depressants, digitalis, phenytoin, anticoagulants, and intrauterine contraceptive devices 6

  • Not yet classified: Causes that don't fit into other categories 2, 3

Additional Systemic and Infectious Causes

Beyond the PALM-COEIN framework, consider:

  • Pregnancy-related complications: Threatened, incomplete, or missed abortion; ectopic pregnancy; trophoblastic disease; placental polyp; subinvolution of the placental site (pregnancy must be excluded first in all reproductive-age women) 3, 7, 6

  • Infections: Endometritis, salpingitis, severe vaginal infections 4, 6

  • Systemic diseases: Cirrhosis, coagulation disorders beyond primary coagulopathies 6

  • Traumatic lesions: Vaginal trauma, foreign bodies 6

  • Cervical pathology: Cervical polyps, cervical erosion, cervicitis, cervical ectropion 4, 6

Critical Diagnostic Principles

Three age-based rules must guide your evaluation:

  • Any abnormal bleeding in reproductive-age women should be considered pregnancy-related until proven otherwise 6

  • Any abnormal bleeding in perimenopausal or postmenopausal women should be considered malignancy until proven otherwise 6

  • Menorrhagia in adolescents should be attributed to coagulopathy until proven otherwise 6

Dysfunctional Uterine Bleeding

When all organic, iatrogenic, and systemic causes have been excluded through appropriate evaluation, the diagnosis of dysfunctional uterine bleeding (DUB) is made by exclusion. 1, 7, 6 This represents anovulatory or ovulatory bleeding without identifiable structural or systemic pathology.

References

Guideline

Dysfunctional Uterine Bleeding Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Abnormal Uterine Bleeding Definition and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Abnormal Uterine Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Meno-metrorrhagia].

Revue medicale de Liege, 1999

Research

[Menometrorrhagia].

La Revue du praticien, 2014

Research

Differential diagnosis of abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.